AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-21028919_ITM" title="Facts and information about Matritech reaches key medicare milestone; monitoring of bladder cancer patients with NMP22 bladderchek test now covered in all 50 states.">Matritech reaches key medicare milestone; monitoring of bladder cancer patients with NMP22 bladderchek test now covered in all 50 states.</a>
Close
Set up an RSS feed that alerts you when new articles from Asia Africa Intelligence Wire are available.
Frequently asked questions about RSS feeds
Matritech reaches key medicare milestone; monitoring of bladder cancer patients with NMP22 bladderchek test now covered in all 50 states.
(From Chemical Business NewsBase - Press Release)
Matritech has reached a significant reimbursement milestone for its NMP22 BladderChek Test. With the exception of a single state, Medicare groups in every state cover the NMP22 BladderChek Test for both monitoring and diagnosis, giving Matritech reimbursement coverage for nearly all …
Related articles from newspapers, magazines, journals, and more
